Leo Pharma
Coverage of Leo Pharma in the Nexus archive.
- Do we want to lead or lag in life sciences?
Europe risks losing its leadership in the pharmaceutical sector due to geopolitical challenges and internal indifference, with the United States' Most-Favored-Nation pricing policy and China's rapid advancements in biotechnology and innovation exacerbating the decline. Europe lags behind in clinical trials, R&D spending, and attracting investment compared to the US and China.
- Leo Pharma Eyes $800 Million Deal Push as IPO Plans Advance
Leo Pharma is moving forward with its IPO plans and is considering a deal worth $800 million. The company has a pharmaceutical manufacturing plant. Leo Pharma's advancements in IPO plans may lead to significant financial gains.
- Drugmaker Leo Pharma Is Said to Pick Banks for Copenhagen IPO
Drugmaker Leo Pharma is preparing for an initial public offering (IPO) on the Copenhagen Stock Exchange. The company is said to be selecting banks to facilitate the IPO process.